Understanding the risk of developing certain cancers can be crucial for proactive health management. When it comes to hereditary cancers, genetic testing can provide valuable insights. In Australia, myDNA and 4Cyte Pathology have partnered to offer comprehensive hereditary cancer screening, making this vital information accessible to individuals.
The Importance of Hereditary Cancer Screening
Hereditary cancers are those passed down through families due to inherited gene mutations. While most cancers are not hereditary, having a family history of cancer can increase the risk. Genetic testing can identify these mutations, allowing for early detection and personalized prevention strategies.
Ovarian Cancer and the Role of Genetics
Ovarian cancer is a type of cancer that begins in the ovaries. While the exact cause is unknown, certain genetic mutations significantly increase the risk of developing ovarian cancer. Some of the genes associated with increased risk include BRCA1, BRCA2, and PALB2.
myDNA and 4Cyte Pathology: A Partnership for Comprehensive Screening
myDNA provides the genetic testing component, analysing DNA for specific gene mutations associated with hereditary cancers, including those related to ovarian cancer. 4Cyte Pathology, a leading provider of pathology services, facilitates the sample collection process at their convenient locations in Victoria, NSW, ACT and QLD.
Benefits of Hereditary Cancer Screening
- Knowledge is Power: Understanding genetic risks allows for more informed decisions.
- Early Detection: If there is a gene mutation, more frequent screenings may be required to detect cancer early, when it’s most treatable.
- Personalised Prevention: Based on your results, doctors recommend strategies to reduce risk, such as lifestyle changes or preventative medications.
The partnership between myDNA and 4Cyte Pathology makes this valuable information accessible, for patients to be more informed.